BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $221,985 | -9.0% | 5,742 | -11.2% | 0.01% | -16.7% |
| Q3 2023 | $244,026 | +19.6% | 6,466 | +44.4% | 0.01% | +20.0% |
| Q2 2023 | $204,017 | +0.2% | 4,478 | -10.8% | 0.01% | -9.1% |
| Q1 2023 | $203,692 | +91241.7% | 5,022 | +14.9% | 0.01% | -15.4% |
| Q4 2022 | $223 | -99.9% | 4,371 | -6.6% | 0.01% | -13.3% |
| Q3 2022 | $252,000 | -15.7% | 4,679 | +0.6% | 0.02% | -11.8% |
| Q2 2022 | $299,000 | -9.1% | 4,651 | +9.6% | 0.02% | +13.3% |
| Q1 2022 | $329,000 | -9.6% | 4,245 | 0.0% | 0.02% | -6.2% |
| Q4 2021 | $364,000 | +17.8% | 4,245 | +10.4% | 0.02% | +14.3% |
| Q3 2021 | $309,000 | -0.3% | 3,845 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $310,000 | -4.3% | 3,845 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $324,000 | +4.9% | 3,845 | 0.0% | 0.02% | -5.9% |
| Q4 2020 | $309,000 | -3.7% | 3,845 | -3.8% | 0.02% | -15.0% |
| Q3 2020 | $321,000 | -11.1% | 3,997 | -4.8% | 0.02% | -16.7% |
| Q2 2020 | $361,000 | -12.8% | 4,197 | -17.7% | 0.02% | -27.3% |
| Q1 2020 | $414,000 | -8.6% | 5,098 | -6.0% | 0.03% | +17.9% |
| Q4 2019 | $453,000 | -7.9% | 5,421 | -3.6% | 0.03% | -15.2% |
| Q3 2019 | $492,000 | +10.8% | 5,621 | +3.7% | 0.03% | +10.0% |
| Q2 2019 | $444,000 | +0.7% | 5,421 | 0.0% | 0.03% | -3.2% |
| Q1 2019 | $441,000 | +23.2% | 5,421 | -0.5% | 0.03% | +6.9% |
| Q4 2018 | $358,000 | -13.7% | 5,446 | +1.1% | 0.03% | +7.4% |
| Q3 2018 | $415,000 | +4.5% | 5,387 | +0.2% | 0.03% | -3.6% |
| Q2 2018 | $397,000 | +40.3% | 5,374 | +23.7% | 0.03% | +40.0% |
| Q1 2018 | $283,000 | -5.7% | 4,345 | -6.5% | 0.02% | -4.8% |
| Q4 2017 | $300,000 | +3.1% | 4,645 | 0.0% | 0.02% | -4.5% |
| Q3 2017 | $291,000 | -3.3% | 4,645 | -6.7% | 0.02% | -4.3% |
| Q2 2017 | $301,000 | +16.7% | 4,980 | 0.0% | 0.02% | +9.5% |
| Q1 2017 | $258,000 | +24.6% | 4,980 | +6.4% | 0.02% | +16.7% |
| Q4 2016 | $207,000 | -9.6% | 4,680 | -2.8% | 0.02% | -14.3% |
| Q3 2016 | $229,000 | +5.0% | 4,817 | 0.0% | 0.02% | 0.0% |
| Q2 2016 | $218,000 | -31.2% | 4,817 | +6.5% | 0.02% | -36.4% |
| Q2 2015 | $317,000 | -74.2% | 4,525 | -74.7% | 0.03% | -74.6% |
| Q1 2015 | $1,227,000 | -2.5% | 17,916 | +4.3% | 0.13% | -6.5% |
| Q4 2014 | $1,259,000 | +4.0% | 17,174 | +1.9% | 0.14% | +0.7% |
| Q3 2014 | $1,210,000 | -0.6% | 16,857 | +0.2% | 0.14% | +2.2% |
| Q2 2014 | $1,217,000 | +1.5% | 16,831 | +3.3% | 0.14% | -2.2% |
| Q1 2014 | $1,199,000 | +8.2% | 16,300 | +2.3% | 0.14% | +6.2% |
| Q4 2013 | $1,108,000 | +6.8% | 15,934 | +0.9% | 0.13% | +6.6% |
| Q3 2013 | $1,037,000 | -4.0% | 15,792 | +1.3% | 0.12% | -9.6% |
| Q2 2013 | $1,080,000 | – | 15,591 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |